Quick answer
Displays at EHL Bio describe three chapters: 2012, 'the beginning of a great journey'; 2014, R&D under 'Challenging execution'; and 2019, 'From innovation to standard' with KGMP-aligned operations—over a decade of steady growth.
EHL Bio since 2012: a growth timeline
Timeline: 2012 beginnings, 2014 R&D, 2019 KGMP standard.
Key facts
- Company
- EHL Bio · South Korea · since 2012
- Khun Kim's role
- Consultation, travel, interpreting, follow-up
- Photography
- Photographed by Khun Kim on site
2012: the beginning
EHL Bio began with a regenerative-medicine goal and built its autologous stem cell research foundation.
2014: R&D
The display states that change is the gateway to opportunity, with competitiveness built through each clinical-trial milestone.
2019: towards standard
Operations were aligned with KGMP and international GMP, turning innovation into standard practice.
Plan with Khun Kim
Khun Kim coordinates consultations with EHL Bio-affiliated teams: sharing your health summary, recent tests and goals, then appointments, travel, interpreting and follow-up after you return to Thailand. Physicians decide suitability; keep your current treatment as advised by your own doctor.
Arrange a consultation with Khun Kim
Share your goal, history and recent tests privately through the channel provided by the team for physician review. Include eGFR, creatinine and UACR if relevant and available. Do not post medical records in public comments.
Contact Khun KimMore on choosing stem cell care
Photo by Khun Kim: 'R&D Challenging execution, since 2014' display · Owner-supplied image; not verification of product identity, licensing or outcomes
Frequently asked questions
Who is this for?
Anyone researching EHL Bio or stem cell hospitals in Korea who wants clear information before deciding.
Where is EHL Bio?
EHL Bio is in South Korea; Khun Kim coordinates appointments and travel from Thailand.
Can I consult before booking?
Yes. Share your details for physician review first; consultation does not guarantee an outcome.
Medical cautions
5 points • reviewed 2026-11-14
Expand
Medical cautions
5 points • reviewed 2026-11-14
- This article is educational information only — not a diagnosis, prescription, or personal medical advice.
- Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
- Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
- Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
- Prices, packages, and service details can change — confirm directly with the provider before paying.
Reviewed and last updated: 2026-11-14
References and sources
10 sources • every claim is traceable
Expand
References and sources
10 sources • every claim is traceable
- 1. EHL Bio — company and research
https://www.ehlbio.co.kr/company/about/
- 2. EHL Bio — GMP facilities (company information)
https://www.ehlbio.co.kr/rd/gmp/
- 3. EHL Bio — contact and locations
https://www.ehlbio.co.kr/company/contact/
- 4. Korean MOHW — regenerative medicine system and plan review
https://mohw.go.kr/board.es?act=view&bid=0027&list_no=1483481&mid=a10503000000
- 5. Korean MOHW — notice 2025-140 on institutions and cell processing
https://www.mohw.go.kr/board.es?act=view&bid=0026&list_no=1487217&mid=a10409020000
- 6. EHL Bio — company history
https://www.ehlbio.co.kr/company/history/
- 7. EHL Bio — stem cell therapeutics pipeline
https://www.ehlbio.co.kr/rd/institute/
- 8. EHL Bio — patents and research papers
https://www.ehlbio.co.kr/rd/patent/
- 9. EHL Bio — EHL-STEM conditioned media
https://www.ehlbio.co.kr/conditioned/
- 10. EHL Bio — immune cells
https://www.ehlbio.co.kr/immune_cell/
Share this page
Last updated: 2026-11-14 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories